Beta Drugs - BETA, 531481 corporate action history

Ex-Date	Bonus Ratio	Record Date
26 Mar 2025	1:20	26 Mar 2025

See all forthcoming Bonus and Splits

Ex-Date	Purpose	Notes
14 Feb 2026	Quarterly Results	-
09 Jan 2026	Others	To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters.
06 Nov 2025	Quarterly Results	-
15 May 2025	Audited Results	-
27 Mar 2025	Others	To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue.
05 Feb 2025	Issue of Bonus & Others	To consider other business matters.
06 Nov 2024	Quarterly Results	-
19 Oct 2024	To consider Fund Raising	-
14 May 2024	Audited Results	-
07 Nov 2023	Quarterly Results & Others	To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE.

See all Rights History for Beta Drugs